Longitudinal Description of Hemorrhoidal Pathology

Study Overview
=================
Brief Summary
-----------------
Hemorrhoidal disease is a common cause of gastroenterology visits. In the United States, it is considered the 3rd most common gastrointestinal diagnosis with nearly 4 million scheduled or emergency visits. In France, self-reported questionnaires estimate that one person in five has suffered at least one hemorrhoidal attack in the past year.

Detailed Description
-----------------
Hemorrhoidal disease significantly alters the quality of life, can be life threatening in case of heavy bleeding and has a significant economic impact. However, there are still many unknowns regarding the different types of hemorrhoidal disease, its symptoms, its natural history, its etiology, its triggering and promoting factors, the associated pathologies, the therapeutic indications, etc. In addition, the therapeutic management is not consensual, especially since the therapeutic arsenal is constantly expanding over the last 20 years with the advent of minimally invasive surgical techniques. The aim of the work is to answer some of these questions on the basis of a prospective cohort of patients.

Official Title
-----------------
Longitudinal Description of Hemorrhoidal Pathology

Conditions
-----------------
Hemorrhoids

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient whose age is ≥ 18 years Consecutive patients consulting for hemorrhoidal disease at the proctology department of the Groupe Hospitalier Paris Saint-Joseph (GHPSJ) between January 1, 2020 and April 30, 2020 French-speaking patient Exclusion Criteria: Patient objecting to participation in the study Patient under guardianship or curatorship Patient deprived of liberty Patient under court protection

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluate the effectiveness of the different treatments proposed according to the type of hemorrhoidal disease (internal, external or both) | Average prolapse score before and after treatment according to the type of hemorrhoidal disease (internal, external or both). | 6 months | 
| Evaluate the effectiveness of the different treatments proposed according to the type of hemorrhoidal disease (internal, external or both) | Average bleeding score before and after treatment according to the type of hemorrhoidal disease (internal, external or both). | 6 months | 
| Evaluate the effectiveness of the different treatments proposed according to the type of hemorrhoidal disease (internal, external or both) | Average quality of life score before and after treatment according to the type of hemorrhoidal disease (internal, external or both). | 6 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluate the proportion of patients consulting for hemorrhoidal disease in the general proctology consultation of a specialized center that also receives emergencies | Proportion of patients in the proctology department consulting for hemorrhoidal disease | 6 months | 
| Describe the various symptoms of hemorrhoidal disease | Proportions of various symptoms of hemorrhoidal disease | 6 months | 
| Search for proctological pathologies associated with hemorrhoidal disease | Prevalence of proctological pathologies associated with hemorrhoidal disease | 6 months | 
| Determine potential risk factors for hemorrhoidal disease | Correlations between potential risk factors and the development of hemorrhoidal disease | 6 months |